These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 29419430)
1. Cytogenetic aberrations in multiple myeloma are associated with shifts in serum immunoglobulin isotypes distribution and levels. Yadav P; Merz M; Mai EK; Försti A; Jauch A; Goldschmidt H; Hemminki K Haematologica; 2018 Apr; 103(4):e162-e164. PubMed ID: 29419430 [No Abstract] [Full Text] [Related]
2. Immunoglobulin heavy and light chain isotypes in multiple myeloma patients. Ansari NA; Owais M; Usha Asian Pac J Cancer Prev; 2007; 8(4):593-6. PubMed ID: 18260735 [TBL] [Abstract][Full Text] [Related]
3. Suppression of the noninvolved pair of the myeloma isotype correlates with poor survival in newly diagnosed and relapsed/refractory patients with myeloma. Ludwig H; Milosavljevic D; Berlanga O; Zojer N; Hübl W; Fritz V; Harding S Am J Hematol; 2016 Mar; 91(3):295-301. PubMed ID: 26662888 [TBL] [Abstract][Full Text] [Related]
4. High incidence of intact or fragmented immunoglobulin in urine of patients with multiple myeloma. Kraj M; Kruk B; Lech-Marańda E; Warzocha K; Prochorec-Sobieszek M Leuk Lymphoma; 2015; 56(12):3348-56. PubMed ID: 25860239 [TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of serum immunoglobulin heavy/light chain ratio in patients with multiple myeloma in complete remission after autologous stem cell transplantation. Tovar N; Fernández de Larrea C; Elena M; Cibeira MT; Aróstegui JI; Rosiñol L; Filella X; Yagüe J; Bladé J Biol Blood Marrow Transplant; 2012 Jul; 18(7):1076-9. PubMed ID: 22430087 [TBL] [Abstract][Full Text] [Related]
6. Cytogenetic studies in patients with multiple myeloma. Kowalczyk JR; Dmoszyńska A; Chobotow M; Sokolowska B Cancer Genet Cytogenet; 1991 Sep; 55(2):173-9. PubMed ID: 1933820 [TBL] [Abstract][Full Text] [Related]
7. Estimation of serum M-protein concentration from polyclonal immunoglobulins: an alternative to serum protein electrophoresis and standard immunochemical procedures. Bergón E; Miravalles E Clin Chem Lab Med; 2008; 46(8):1156-62. PubMed ID: 18605957 [TBL] [Abstract][Full Text] [Related]
8. Production of immunoglobulin isotypes by peripheral blood mononuclear cells in multiple myeloma. Säily M; Koistinen P; Laine S; Soppi E; Sovolainen ER Acta Haematol; 1994; 92(2):71-8. PubMed ID: 7817707 [TBL] [Abstract][Full Text] [Related]
9. Deciphering the immunoglobulin code in multiple myeloma. Szczepanski T Haematologica; 2006 Jun; 91(6):725B. PubMed ID: 16769570 [No Abstract] [Full Text] [Related]
10. Immunoglobulin and chromosome abnormalities in multiple myeloma. Rosenberg EB; Liu CH; Yang SL; Wang CH; Hwang TS Taiwan Yi Xue Hui Za Zhi; 1970 Aug; 69(8):399-404. PubMed ID: 4098498 [No Abstract] [Full Text] [Related]
11. Light-chain isotype-associated B cell suppression in multiple myeloma. Leonard RC Lancet; 1987 Apr; 1(8538):916. PubMed ID: 2882310 [No Abstract] [Full Text] [Related]
12. Cytoplasmic heavy and light chain isotypic suppression by peripheral Fc gamma + T-cells from multiple myeloma. Guglielmo P; Cunsolo F; Milone G; Di Raimondo F; Giustolisi R; Cacciola E Haematologica; 1987; 72(5):465-8. PubMed ID: 2961667 [No Abstract] [Full Text] [Related]
13. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution. Magnano L; Fernández de Larrea C; Elena M; Cibeira MT; Tovar N; Aróstegui JI; Pedrosa F; Rosiñol L; Filella X; Yagüe J; Bladé J Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e71-7. PubMed ID: 27013181 [TBL] [Abstract][Full Text] [Related]
14. [Analysis of the relationship of heavy/light chain pairs of immunoglobulin (Hevylite) to the results of gel electrophoresis and nefelometric examination of serum proteins at the time of multiple myeloma diagnosis]. Ščudla V; Lochman P; Pika T; Zapletalová J; Minařík J; Bačovský J Cas Lek Cesk; 2015; 154(6):292-302. PubMed ID: 26750626 [TBL] [Abstract][Full Text] [Related]
15. Benefits of new immunoglobulin-derived biomarkers for the diagnosis and follow-up of patients with dysglobulinemia. Ermak N; Nguyen-Khoa T; Alyanakian MA Ann Biol Clin (Paris); 2016 Oct; 74(5):597-605. PubMed ID: 27707674 [TBL] [Abstract][Full Text] [Related]
16. Levels of uninvolved immunoglobulins predict clinical status and progression-free survival for multiple myeloma patients. Harutyunyan NM; Vardanyan S; Ghermezi M; Gottlieb J; Berenson A; Andreu-Vieyra C; Berenson JR Br J Haematol; 2016 Jul; 174(1):81-7. PubMed ID: 27017948 [TBL] [Abstract][Full Text] [Related]
17. Role of serum free light chain assay in the detection of early relapse and prediction of prognosis after relapse in multiple myeloma patients treated upfront with novel agents. Tacchetti P; Pezzi A; Zamagni E; Pantani L; Rocchi S; Zannetti BA; Mancuso K; Rizzello I; Cavo M Haematologica; 2017 Mar; 102(3):e104-e107. PubMed ID: 27909220 [No Abstract] [Full Text] [Related]
18. Cytogenetic data as a prognostic factor in multiple myeloma patients: involvement of 1p12 region an adverse prognostic factor. Panani AD; Ferti AD; Papaxoinis C; Raptis SA; Roussos Ch Anticancer Res; 2004; 24(6):4141-6. PubMed ID: 15736465 [TBL] [Abstract][Full Text] [Related]
19. [Clinical value of the blood measurement of the free light chains of immunoglobulins]. Bidet A; Marit G; Bérard AM Ann Biol Clin (Paris); 2008; 66(4):427-31. PubMed ID: 18725344 [TBL] [Abstract][Full Text] [Related]
20. IgG subclass distribution in patients with multiple myeloma or with monoclonal gammopathy of undetermined significance. Papadea C; Reimer CB; Check IJ Ann Clin Lab Sci; 1989; 19(1):27-37. PubMed ID: 2492788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]